Literature DB >> 6253571

Production and release of platelet-activating factor (PAF); dissociation from degranulation and superoxide production in the human neutrophil.

S J Betz, P M Henson.   

Abstract

The generation of human PAF was examined using purified neutrophils from normal and CGD donors. PAF release occurred in response to all of the neutrophil stimuli examined, including PMA and the calcium ionophore A23187, which initiate the relatively selective release of specific granule constituents. PAF release was dissociable from neutrophil degranulation by 1) the lack of correlation between PAF titers and extent of enzyme release for different stimuli, 2) the strict dependence of PAF release on the presence of extracellular Ca++, 3) the different kinetics for release of PAF and granule enzymes, and 4) the ability of neutrophils significantly depleted of azurophil and specific granule constituents to release normal levels of PAF when stimulated with opsonized zymosan. PAF release was also normal, if not elevated, in neutrophils from patients with chronic granulomatous disease, demonstrating that the formation and release of PAF does not depend upon an intact superoxide generating pathway.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253571

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Platelet-activating factor may participate in signal transduction processes in rabbit leukocytes.

Authors:  A G Stewart; T Harris
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Synergistic platelet activation by aggregates of IgG and the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.

Authors:  F H Valone
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

Review 3.  Biology and biochemistry of platelet-activating factor.

Authors:  J T O'Flaherty; R L Wykle
Journal:  Clin Rev Allergy       Date:  1983-09

4.  Inflammatory mediators released by complement-derived peptides.

Authors:  H Bult; A G Herman
Journal:  Agents Actions       Date:  1983-08

5.  Platelet serotonin release by human polymorphonuclear leucocytes stimulated by cotton dust bacteria.

Authors:  P G Holt; B J Holt; L Beijer; R Rylander
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

6.  Binding and metabolism of platelet-activating factor by human neutrophils.

Authors:  J T O'Flaherty; J R Surles; J Redman; D Jacobson; C Piantadosi; R L Wykle
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

7.  Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.

Authors:  J P Seale; S Nourshargh; P G Hellewell; T J Williams
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 8.  Bacterial meningitis: mechanisms of disease and therapy.

Authors:  R F Kornelisse; R de Groot; H J Neijens
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

9.  Platelet activating factor (PAF) and lyso-PAF in psoriasis.

Authors:  M R Judge; R M Barr; A I Mallet; F Courtney; A Kobza Black; M W Greaves
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

10.  Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia.

Authors:  G Camussi; F Bussolino; C Tetta; F Caligaris Cappio; R Coda; E Macchiorlatti; M Alberton; C Roffinello; G Segoloni
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.